214 related articles for article (PubMed ID: 10732663)
1. Lack of desipramine toxicity with citalopram.
Ashton AK
J Clin Psychiatry; 2000 Feb; 61(2):144. PubMed ID: 10732663
[No Abstract] [Full Text] [Related]
2. Managing rapid metabolizers of antidepressants.
Kraus RP; Diaz P; McEachran A
Depress Anxiety; 1996-1997; 4(6):320-7. PubMed ID: 9166660
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic fluvoxamine-clomipramine interaction with favorable therapeutic consequences in therapy-resistant depressive patient.
Conus P; Bondolfi G; Eap CB; Macciardi F; Baumann P
Pharmacopsychiatry; 1996 May; 29(3):108-10. PubMed ID: 8738315
[TBL] [Abstract][Full Text] [Related]
4. Citalopram: an interaction study with clomipramine in a patient heterozygous for CYP2D6 genotype.
Haffen E; Vandel P; Broly F; Vandel S; Sechter D; Bizouard P; Bechtel PR
Pharmacopsychiatry; 1999 Nov; 32(6):232-4. PubMed ID: 10599932
[TBL] [Abstract][Full Text] [Related]
5. Effect of desvenlafaxine on the cytochrome P450 2D6 enzyme system.
Preskorn SH; Nichols AI; Paul J; Patroneva AL; Helzner EC; Guico-Pabia CJ
J Psychiatr Pract; 2008 Nov; 14(6):368-78. PubMed ID: 19057238
[TBL] [Abstract][Full Text] [Related]
6. Anticholinergic toxic syndrome with venlafaxine-desipramine combination.
Benazzi F
Pharmacopsychiatry; 1998 Jan; 31(1):36-7. PubMed ID: 9524985
[No Abstract] [Full Text] [Related]
7. Ultrarapid metabolism of clomipramine in a therapy-resistant depressive patient, as confirmed by CYP2 D6 genotyping.
Baumann P; Broly F; Kosel M; Eap CB
Pharmacopsychiatry; 1998 Mar; 31(2):72. PubMed ID: 9562213
[No Abstract] [Full Text] [Related]
8. An in vitro mechanistic study to elucidate the desipramine/bupropion clinical drug-drug interaction.
Reese MJ; Wurm RM; Muir KT; Generaux GT; St John-Williams L; McConn DJ
Drug Metab Dispos; 2008 Jul; 36(7):1198-201. PubMed ID: 18420781
[TBL] [Abstract][Full Text] [Related]
9. Effect of nortriptyline and paroxetine on CYP2D6 activity in depressed elderly patients.
Solai LK; Pollock BG; Mulsant BH; Frye RF; Miller MD; Sweet RA; Kirshner M; Sorisio D; Begley A; Reynolds CF
J Clin Psychopharmacol; 2002 Oct; 22(5):481-6. PubMed ID: 12352271
[TBL] [Abstract][Full Text] [Related]
10. Exacerbation of extrapyramidal symptoms with paroxetine.
Arya DK; McKenzie J; Worrall N
Aust N Z J Psychiatry; 1995 Sep; 29(3):521-2. PubMed ID: 8573063
[No Abstract] [Full Text] [Related]
11. Effect of the novel anxiolytic drug deramciclane on cytochrome P(450) 2D6 activity as measured by desipramine pharmacokinetics.
Laine K; De Bruyn S; Björklund H; Rouru J; Hänninen J; Scheinin H; Anttila M
Eur J Clin Pharmacol; 2004 Feb; 59(12):893-8. PubMed ID: 14730412
[TBL] [Abstract][Full Text] [Related]
12. Clomipramine, fluoxetine and CYP2D6 metabolic capacity in depressed patients.
Vandel P; Haffen E; Nezelof S; Broly F; Kantelip JP; Sechter D
Hum Psychopharmacol; 2004 Jul; 19(5):293-8. PubMed ID: 15252821
[TBL] [Abstract][Full Text] [Related]
13. Desipramine pharmacokinetics when coadministered with paroxetine or sertraline in extensive metabolizers.
Alderman J; Preskorn SH; Greenblatt DJ; Harrison W; Penenberg D; Allison J; Chung M
J Clin Psychopharmacol; 1997 Aug; 17(4):284-91. PubMed ID: 9241008
[TBL] [Abstract][Full Text] [Related]
14. Severe adverse drug events under combination of nortriptyline and melperone due to pharmacokinetic interaction.
Hefner G; Geschke K; Hiemke C
J Clin Psychopharmacol; 2014 Jun; 34(3):394-6. PubMed ID: 24743723
[No Abstract] [Full Text] [Related]
15. Genetics in pharmacokinetics?
Hartter S
Am J Psychiatry; 2004 Jul; 161(7):1308-9; author reply 1309. PubMed ID: 15229072
[No Abstract] [Full Text] [Related]
16. Fluoxetine and desipramine: a strategy for augmenting anti-depressant response.
Eisen A
Pharmacopsychiatry; 1989 Nov; 22(6):272-3. PubMed ID: 2616636
[No Abstract] [Full Text] [Related]
17. Withdrawal after discontinuation of paroxetine.
Arya DK
Aust N Z J Psychiatry; 1996 Oct; 30(5):702. PubMed ID: 8902183
[No Abstract] [Full Text] [Related]
18. [A trial of treating depressive states with cipramil].
Iakovlev VA; Belinskiĭ AV; Dorovskikh IV
Voen Med Zh; 2000 Jun; 321(6):53-6. PubMed ID: 10929517
[No Abstract] [Full Text] [Related]
19. Rates of in vivo methylation of desipramine and nortriptyline.
Kurpius MP; Alexander B
Pharmacotherapy; 2006 Apr; 26(4):505-10. PubMed ID: 16553509
[TBL] [Abstract][Full Text] [Related]
20. [Unipolar depression suddenly switches to hypomania in a patient who has just started taking venlafaxine].
Krol DG; Nolen WA
Tijdschr Psychiatr; 2006; 48(5):405-8. PubMed ID: 16956033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
